赛诺菲喜保宁进医保了吗?
(Vigabatrin tablets) is currently the only effective therapeutic drug other than glucocorticoids. After the 1990s, European and other countries began to use vigabatrin for the treatment of infantile spasms (IS). The U.S. Food and Drug Administration approved the drug as an orphan drug for the treatment of IS in 2000. In 2009, it was approved for use in children with IS between 1 month and 2 years old. In 2012, the World Tuberous Sclerosis Congress clearly recommended the use of vigabatrin as a treatment for tuberous sclerosis. (TSC) and IS are first-line treatments. The drug has the characteristics of fast onset, good effect and few adverse reactions. So, has Sanofi Vigabatrin been included in medical insurance?
The answer is no, because Sanofi Vigabatrin has not yet been approved by the National Medical Products Administration (NMPA) to be marketed in China. Therefore, patients currently cannot buy this drug in China, and they cannot be included in medical insurance. Before Sanofi Vigabatrin is officially launched in China, patients can choose to purchase drugs overseas to meet their actual treatment needs.
Sanofi is a world-leading diversified pharmaceutical and health company. Its six core growth platforms for sustainable development are emerging markets, vaccines, health pharmaceuticals, diabetes treatment and innovative products. Currently, Vigabatrin (vigabatrin tablets) produced by it has been launched in many countries and regions, and patients in need can choose to purchase it based on their actual needs.
According to Medical Companion Travel, a box of French Sanofi's Turkish version is priced at about $1,500, and the drug specification is 500 mg x 100 capsules per box. Domestic patients in need can either go abroad to purchase local medicines in person, or contact some professional and formal overseas medical service organizations in China (such as Medical Companion Travel) to obtain purchase channels for the required medicines. At that time, the institution will deliver the medicines to patients through direct mail, and patients can purchase genuine and good medicines without going abroad.
Recommended hot articles: /newsDetail/93738.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)